16 reports

  • ANGINA PECTORIS MARKET IN APAC
  • Introduction
  • Angina
  • Beta-Blocker
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG

Angina (Angina Pectoris) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 ##.

  • Angina
  • Chronic Disease
  • World
  • Demand
  • Product Initiative

Hoffmann-La Roche Ltd ##. ## AstraZeneca PLC ##. ## TSH Biopharm Corporation Limited List of Tables Table ## Global Angina Pectoris Drugs Market Outlook, By Region (2014-2023) ($MN) Table ## Global Angina Pectoris Drugs Market Outlook, By Drug Class (2014-2023) ($MN) Table ## Global

  • Angina
  • Asia
  • Europe
  • World
  • Forecast

FIG. ## Age and Gender Specific Incidence of Angina Pectoris in the U. K.

  • Angina
  • United States
  • Forecast

Angina (Angina Pectoris) - Epidemiology Forecast to 2027 ##.

  • Angina
  • France
  • Germany
  • Italy
  • Spain

Angina (Angina Pectoris) : ##MM Market Analysis ##. ##. ##MM Market Size of Angina (Angina Pectoris) ##. ##. ##MM Percentage Share of drugs marketed for Angina (Angina Pectoris) ##. ##. ##MM Market Sales of Angina (Angina Pectoris) by Pro

  • Angina
  • Chronic Disease
  • Pathology
  • DISEASE DEFINITION
  • NITRATES
  • Angina
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Angina (Angina Pectoris) - Overview
  • Angina (Angina Pectoris) - Dormant Projects
  • Angina
  • Hospital
  • United States
  • Product Initiative
  • Juventas Therapeutics, Inc.
  • Angina (Angina Pectoris) - Overview
  • Angina (Angina Pectoris) - Therapeutics Assessment
  • Angina
  • Cardiovascular Disease
  • Chronic Disease
  • United States
  • Product Initiative
  • CHRONIC STABLE ANGINA THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2017*
  • CHRONIC STABLE ANGINA THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY TRIAL STATUS, 2017*
  • Angina
  • Cardiology
  • Chronic Disease
  • Clinical Trial
  • Gilead Sciences, Inc.
  • Proportion of Chronic Stable Angina to Cardiovascular Clinical Trials, G7 Countries (%), 2016*
  • Chronic Stable Angina Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Angina
  • Chronic Disease
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • Vasospastic Angina Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Vasospastic Angina Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Angina
  • Chronic Disease
  • World
  • Product Initiative
  • Otsuka Pharmaceutical Co., Ltd.
  • Refractory Angina Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Refractory Angina Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Angina
  • Chronic Disease
  • World
  • Product Initiative
  • Les Laboratoires Servier SAS
  • Stable Angina Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Stable Angina Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Angina
  • Cardiovascular Disease
  • Cardiovascular Drug
  • World
  • Product Initiative
  • Proportion of Unstable Angina to Cardiovascular Clinical Trials, E7 Countries (%), 2016*
  • Clinical Trials by G7 Countries: Proportion of Unstable Angina to Cardiovascular Clinical Trials
  • Angina
  • Cardiovascular Disease
  • Cardiovascular Drug
  • World
  • Product Initiative

Angina (Angina Pectoris) Overview ##.

  • Angina
  • Chronic Disease
  • Pathology